Provided by Tiger Trade Technology Pte. Ltd.

Hims & Hers Health Inc.

20.82
-0.5168-2.42%
Volume:7.92M
Turnover:168.01M
Market Cap:4.74B
PE:40.65
High:22.00
Open:21.70
Low:20.57
Close:21.34
52wk High:70.43
52wk Low:13.74
Shares:227.65M
Float Shares:197.51M
Volume Ratio:0.89
T/O Rate:4.01%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.5123
EPS(LYR):0.5123
ROE:25.23%
ROA:5.29%
PB:8.76
PE(LYR):40.65

Loading ...

Eli Lilly Stock (LLY) Falls on News Hims & Hers Is Selling a $49 Weight-Loss Pill

TIPRANKS
·
Feb 06

Analysts Conflicted on These Healthcare Names: Masimo (MASI) and Hims & Hers Health (HIMS)

TIPRANKS
·
Feb 06

Novo Nordisk warnt vor illegalen Semaglutid-Kopien von Hims & Hers

Reuters
·
Feb 05

Novo Nordisk issues statement on ‘inauthentic’ Hims & Hers semaglutide pill

TIPRANKS
·
Feb 05

Stock Track | Hims & Hers Health Soars 10.37% in Pre-market After Launching $49 Compounded Copy of Wegovy Weight-Loss Pill

Stock Track
·
Feb 05

Hims & Hers Stock Jumps On Compounded Wegovy Launch

Benzinga_recent_news
·
Feb 05

INSTANT VIEW-Hims and Hers Health's compounded Wegovy pill offering fuels market jitters

Reuters
·
Feb 05

Hims & Hers Shares up 13.1% After Reuters Reports Co Launches Copy of Wegovy Pill at $49

THOMSON REUTERS
·
Feb 05

Hims offers cheapest GLP-1 weight-loss pill in US in a shock to Novo, Lilly

Reuters
·
Feb 05

Stock Track | Hims & Hers Health Soars 9.45% in Pre-market After Launching $49 Wegovy Pill Copy

Stock Track
·
Feb 05

Hims & Hers Health Shares Surge Nearly 14% in Pre-Market Trading Following Launch of Generic Wegovy Alternative

Stock News
·
Feb 05

Hims & Hers confirms $49 monthly starting price for Wegovy pill copy

TIPRANKS
·
Feb 05

BRIEF-Hims & Hers Expands Personalized Weight Loss Portfolio With Access To Compounded Semaglutide Pills Starting At $49/Month*

Reuters
·
Feb 05

Hims & Hers Health Inc. verdoppelt seine Betriebsfläche und führt neue Semaglutid-Pille zur Gewichtsreduktion ein

Reuters
·
Feb 05

Hims & Hers Doubles Facility Footprint and Launches Compounded Semaglutide Pill

Reuters
·
Feb 05

Hims & Hers Health Inc: This Compounded Product Uses a Different Formulation and Delivery System Than FDA-Approved Oral Semaglutide

THOMSON REUTERS
·
Feb 05

Hims & Hers to Offer Copy of Novo's Wegovy Pill for $49 per Month, Reuters Reports

MT Newswires Live
·
Feb 05

Hims and Hers Health Stock Soars 12% and Novo-Nordisk Falls 6% After Hims and Hers Launches Copy of Wegovy Pill at $49

Reuters
·
Feb 05

BRIEF-Novo Nordisk Shares Down 2.6% After Reuters Reports Hims And Hers Health Launches Copy Of Wegovy Pill At $49

Reuters
·
Feb 05

Hims & Hers Health Shares Rise 4.4%

THOMSON REUTERS
·
Feb 05